Stay updated on Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.

Latest updates to the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH announcement banner appears above the ClinicalTrials.gov navigation, describing transition-related terminology updates across NIH content.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation with an access-restricted message. This blocks users from viewing trial details and related documents.SummaryDifference23%

- Check58 days agoChange DetectedThe page's revision label was updated from Revision: v3.6.5 to Revision: v3.6.6, signaling a new build of the page rather than a substantive content change.SummaryDifference0.0%

- Check65 days agoChange DetectedA new NIH grant/contract entry, '2017 ( U.S. NIH Grant/Contract )', was added to the study's identifiers. This reflects funding information associated with the trial.SummaryDifference0.0%

Stay in the know with updates to Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arginase Inhibitor & Checkpoint Therapy in Solid Tumors Clinical Trial page.